Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-07-15

Clinical Trial Update: Sertraline Combined With Fluvoxamine in the Treatment of Refractory Obsessive-compulsive Disorder [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial exploring sertraline combined with fluvoxamine for refractory obsessive-compulsive disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fluvoxamine (fluvoxamine)
  • Sertraline (Sertraline)

Snippet

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University | Conditions: OCD | Phase 4 | Status: UNKNOWN